USANA Health Sciences, Inc. - Q1 2011 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 2, 2011. USANA Health Sciences, Inc. develops and manufactures nutritional and personal care products sold internationally through a network marketing system. The company operates in two primary geographic regions: North America and Asia Pacific. As of the period end, the company reported approximately 213,000 active Associates and 70,000 active Preferred Customers globally.
Key Financial Metrics
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Sales | $143.6 million | $119.1 million |
| Gross Profit | $117.9 million | $96.1 million |
| Gross Margin | 82.1% | 80.7% |
| Net Earnings | $11.4 million | $9.6 million |
| Diluted EPS | $0.70 | $0.62 |
| Operating Cash Flow | $17.5 million | $15.1 million |
| Cash and Equivalents (End of Period) | $32.7 million | $21.5 million |
| Debt | $0 (No outstanding debt) | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 20.6% year-over-year, driven primarily by a 84.4% surge in sales in the Greater China region (led by Hong Kong and the BabyCare acquisition) and favorable currency exchange rates ($4.2 million impact).
- Profitability: Net earnings rose 17.7% to $11.4 million. Gross margin improved to 82.1% due to currency benefits, lower freight costs, and reduced raw material costs.
- Expense Trends: Selling, General, and Administrative (SG&A) expenses increased to 25.0% of net sales (from 23.1%) due to BabyCare integration costs, increased U.S. marketing spend, and the Asia Pacific Convention held in Q1 2011. Associate incentives decreased slightly as a percentage of sales to 45.1%.
- Customer Base: Active Associates in North America declined by 11.7% due to difficult economic conditions, while the Asia Pacific region saw an 18.2% increase, largely driven by Greater China.
Outlook, Risks, and Management Commentary
- Strategic Focus: Management is prioritizing the integration of BabyCare in China and expects Hong Kong sales to decline in 2011 as Associates shift focus to the Chinese market. North American growth remains a primary objective despite economic headwinds.
- Liquidity: On April 27, 2011, the company amended its credit facility with Bank of America, increasing the line of credit to $60 million and extending the maturity to May 2016. The company currently has no outstanding debt.
- Share Repurchases: The company repurchased and retired 251,000 shares for $8.5 million during the quarter. Approximately $23.2 million remains available under the repurchase plan.
- Risks: Key risks include dependence on the network marketing model, fluctuations in foreign currency exchange rates (68.4% of sales are international), regulatory changes in international markets (specifically China), and the ability to attract and retain Associates.
Investor Verification Checklist
- Verify the sustainability of sales growth in Greater China, specifically the transition of volume from Hong Kong to mainland China via BabyCare.
- Monitor the impact of the strengthening U.S. dollar on future reported earnings, given the high percentage of international sales.
- Assess the effectiveness of new marketing and training tools in reversing the decline of active Associates in North America.
- Review the timeline for obtaining direct selling licenses for BabyCare in additional Chinese provinces.
- Confirm compliance with the new credit facility covenants (Adjusted EBITDA and debt-to-EBITDA ratios).